Dr. Neidhart is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4144 Cristo Rey St
Farmington, NM 87401Phone+1 505-564-6850Fax+1 505-564-6890- Is this information wrong?
Education & Training
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Ohio State University HospitalResidency, Internal Medicine, 1995 - 1998
University of New Mexico School of MedicineClass of 1995
Certifications & Licensure
NM State Medical License 2002 - 2026
CO State Medical License 2002 - 2025
AL State Medical License 1999 - 2024
OH State Medical License 1996 - 2022- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
Clinical Trials
- Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors Start of enrollment: 2006 May 01
- Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 1 citationsEfficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen.Jonathan Afari, Tanya M Spektor, Carley Turner, Alexa Cohen, Alberto Bessudo, Haresh Jhangiani, Nashat Gabrail, Samir Kubba, Jeffrey D Neidhart, Shahrooz Eshaghian, Re...> ;Experimental Hematology. 2022 Oct 1
- 38 citationsA randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquam...Edward B. Garon, Jeffrey D. Neidhart, Nashat Y Gabrail, Moacyr Ribeiro de Oliveira, Jai Balkissoon, Fairooz F. Kabbinavar> ;Oncotargets and Therapy. 2016 Nov 30
- 127 citationsFirst-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignanciesGlen J. Weiss, Joseph Chao, Jeffrey D. Neidhart, Ramesh K. Ramanathan, Dawn Bassett, James A. Neidhart, Chung Hang Jonathan Choi, Warren Chow, Vincent Chung, Stephen J...> ;Investigational New Drugs. 2013 Feb 9
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- San Juan Regional Medical CenterFarmington, New Mexico
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
